Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,637.08
(
2.01%
)
US TECH 100
23,726.80
(
1.91%
)
Dow Jones
46,588.10
(
2.22%
)
Brent Oil
97.97
(
-9.40%
)
Bitcoin
71,473.99
(
5.36%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RockRat

Send PM Follow Ignore
Followers 10
Posts 903
Boards Moderated 0
Alias Born 12/19/2005

RockRat

Re: DewDiligence post# 200876

Wednesday, 04/20/2016 11:57:02 PM

Wednesday, April 20, 2016 11:57:02 PM

Post# of 257269
Wow! The old Zymogenetics program. Aside from the questions of therapeutic utility and size of market, after all the testing it failed to get through, one wonders how much patent protection is left, too. This company has the makings of a classic bio short candidate.

Regards, RockRat

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today